Background: We previously identified a local renin-angiotensin system (RAS) regulating the differentiation of an isolated population of human pancreatic progenitor cells. Major RAS components that regulate organogenesis have been also described in embryos; however, it is not known whether a local RAS is present in the fetal pancreas. We now hypothesize that angiotensin II type 1 (AT 1 ) and type 2 (AT 2 ) receptors are expressed in mouse embryonic pancreas and involved in regulating endocrine cell development. Results: Differential expression of AT 1 and AT 2 receptors was observed in the mouse pancreata in late embryogenesis. Systemic AT 2 , but not AT 1 , receptor blockade during the second transition in pancreatic development (from embryonic day 12.0 onward) reduced the b-cell to a-cell ratio of the neonate islets, impaired their insulin secretory function and the glucose tolerance of the pups. Studies with pancreas explants ex vivo revealed regulation by AT 2 receptors of the differentiation of pancreatic progenitors into insulin-producing cells and of the proliferation of the differentiated cell, actions that did not result from reduced angiogenesis as a secondary effect of AT 2 receptor antagonism. Conclusions: These data revealed an AT 2 receptor-mediated mechanism regulating pancreatic endocrine cell development in vivo. Developmental Dynamics 243:415-427, 2014. V C 2013 Wiley Periodicals, Inc.Key words: renin-angiotensin system; fetal pancreas; islet; insulin
Key findings:Differential expression of AT 1 and AT 2 receptors was identified in mouse pancreas during pancreatic development. AT 2 receptor, but not AT 1 receptor, blockade during the second transition stage of pancreatic development altered islet cell composition and impaired both insulin secretory function of neonatal islets and glucose tolerance of the pups. Pancreas explants ex vivo data showed that AT 2 receptors were essential for the differentiation of pancreatic progenitors into insulin producing cells, as well as for proliferation of the differentiated cells. No evidence was found to suggest that AT 2 receptor regulation of b-cell development is a secondary effect of angiotensin II-induced vascular endothelial growth factor-driven angiogenesis.